Bacterial Vaginosis, Vaginal Health
Conditions
Keywords
Vaginal pH Balance, Vaginal Flora, Women's Health
Brief summary
This is a virtual single-group clinical trial that will last 12 weeks. Participants will use The Killer® (Boric Acid Suppositories) once daily for 7 consecutive days when they feel that they are experiencing any of the common signs of vaginal imbalance like vaginal malodor, vaginal irritation, and/or vaginal itching. Participants will complete a questionnaire before using the product and on Days 3 and 7 of using the product. They will also complete a vaginal swab pH test before using the product and after 7 days of using the product (Day 8).
Interventions
Participants will complete a baseline questionnaire and a vaginal pH test before using the product, and additional questionnaires and a pH test after 3 and 7 days of product use.
Sponsors
Study design
Eligibility
Inclusion criteria
* Female at birth * Aged 18+ * Interested in maintaining a calm, soothed, and healthy vaginal environment and balanced vaginal pH levels * Regularly experience atypical vaginal smell, discharge, itching, swelling, irritation, pain or - burning during sex, and/or a burning sensation while urinating * Willing to avoid introducing any products or new forms of prescription medication or supplements targeting vaginal health during the study period * Has used a boric acid suppository before * Willing to avoid the use of any intra-vaginal products during the study product use * Willing and able to follow the study protocol
Exclusion criteria
* Surgeries or invasive treatments in the last six months or planned during the study period * Introduced any products or forms of prescription medication or supplements targeting vaginal health in the last 12 weeks * Known allergies to the product ingredients * Diagnosed with chronic health conditions impacting participation * Pregnant, breastfeeding, or trying to conceive * History of substance abuse * Current or former smoker within the past six months * Unwilling to follow the study protocol * Currently participating in any other clinical trial or perception study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Vaginal Health and Balance | Baseline, Day 3, Day 7, and Day 8 | Evaluation of vaginal health and balance via participant questionnaires. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Participant Perception of Product Convenience | Day 3 and Day 7 | Assessment of participant perception of the convenience of the boric acid suppository compared to other boric acid suppositories via questionnaires. |
Countries
United States